Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus

被引:2
|
作者
Pacilli, Antonio [1 ]
Lamacchia, Olga [2 ]
Fontana, Andrea [3 ]
Copetti, Massimiliano [3 ]
Cignarelli, Mauro [2 ]
Trischitta, Vincenzo [4 ,5 ]
De Cosmo, Salvatore [1 ]
机构
[1] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy
[2] Univ Foggia, Dept Surg & Med Sci, Unit Endocrinol & Metab Dis, Foggia, FG, Italy
[3] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy
[4] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy
[5] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy
来源
PLOS ONE | 2015年 / 10卷 / 04期
关键词
GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; METAANALYSIS; CHOLESTEROL; PEOPLE; DISEASE; EVENTS; COMPLICATIONS; PREVENTION;
D O I
10.1371/journal.pone.0124536
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background To investigate prospectively the relationship between target values of glycated hemoglobin, blood pressure and LDL-cholesterol, as considered in a combined fashion, and all-cause mortality in patients with type 2 diabetes mellitus. Methods Two cohorts of patients with type 2 diabetes mellitus, the Gargano Mortality Study (n=810) and the Foggia Mortality Study (n=929), were investigated. A weighted target risk score was built as a weight linear combination of the recommended targets reached by each patient. Results In the Gargano Mortality Study and in the Foggia Mortality Study (mean follow up=7.4 and 5.5 years, respectively), 161 (19.9%) and 220 (23.7%) patients died, with an age and sex adjusted annual incidence rate of 2.1 and 2.8 per 100 person-years, respectively. In both study samples the weighted target risk score tended to be linearly associated with all-cause mortality (HR for one point increment=1.30, 95% CI: 1.11-1.53, p=0.001, and HR=1.08, 95% CI: 0.95-1.24, p=0.243, respectively). When the two cohorts were pooled and analyzed together, a clear association between weighted target risk score and all-cause mortality was observed (HR for one point increment=1.17, 95% CI: 1.05-1.30, p=0.004). This counter-intuitive association was no longer observable in a model including age, sex, body mass index, smoking habit, estimated glomerular filtration rate, albuminuria and anti-diabetic, anti-hypertensive and anti-dyslipidemic treatment as covariates (HR for one point increment=0.99, 95% CI: 0.87-1.12, p=0.852). Conclusions In a real life clinical set of patients with type 2 diabetes mellitus, the combination of recommended target values of established cardiovascular risk factors is not associated with allcause mortality.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Diabetes mellitus, subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality
    Kuller, LH
    Velentgas, P
    Barzilay, J
    Beauchamp, NJ
    O'Leary, DH
    Savage, PJ
    CIRCULATION, 1999, 99 (08) : 1114 - 1114
  • [22] All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic
    Al-Rubeaan, Khalid
    Youssef, Amira M.
    Ibrahim, Heba M.
    Al-Sharqawi, Ahmad H.
    AlQumaidi, Hamid
    AlNaqeb, Dhekra
    Aburisheh, Khaled H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 118 : 130 - 139
  • [23] Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes
    Menzaghi, Claudia
    Bacci, Simonetta
    Salvemini, Lucia
    Mendonca, Christine
    Palladino, Giuseppe
    Fontana, Andrea
    De Bonis, Concetta
    Marucci, Antonella
    Goheen, Elizabeth
    Prudente, Sabrina
    Morini, Eleonora
    Rizza, Stefano
    Kanagaki, Alyssa
    Fini, Grazia
    Mangiacotti, Davide
    Federici, Massimo
    De Cosmo, Salvatore
    Pellegrini, Fabio
    Doria, Alessandro
    Trischitta, Vincenzo
    PLOS ONE, 2013, 8 (06):
  • [24] Resistin, major cardiovascular events and all-cause mortality in patients with type 2 diabetes
    Menzaghi, C.
    Bacci, S.
    Salvemini, L.
    Powers, C.
    Fontana, A.
    De Cosmo, S.
    Pellegrini, F.
    Doria, A.
    Trischitta, V.
    DIABETOLOGIA, 2012, 55 : S62 - S63
  • [25] Resistin, Major Cardiovascular Events and All-Cause Mortality in Patients With Type 2 Diabetes
    Menzaghi, Claudia
    Bacci, Simonetta
    Salvemini, Lucia
    Powers, Christine
    Palladino, Giuseppe
    Marucci, Antonella
    De Bonis, Concetta
    Mangiacotti, Davide
    Fini, Grazia
    Prudente, Sabrina
    De Cosmo, Salvatore
    Doria, Alessandro
    Trischitta, Vincenzo
    DIABETES, 2012, 61 : A114 - A114
  • [26] Association of echocardiographic parameters with all-cause and cardiovascular mortality in patients with type 2 diabetes
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Liu, Chiu-Shong
    Lin, Chih-Hsueh
    Yang, Shing-Yu
    Li, Tsai-Chung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 408
  • [27] Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus
    Zhang, Wenbin
    Li, Duanbin
    Shan, Yu
    Tao, Yecheng
    Chen, Qingqing
    Hu, Tianli
    Gao, Menghan
    Chen, Zhezhe
    Jiang, Hangpan
    Du, Changqin
    Wang, Min
    Guo, Kai
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [28] Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus
    Weiss, A.
    Boaz, M.
    Beloosesky, Y.
    Kornowski, R.
    Grossman, E.
    DIABETIC MEDICINE, 2009, 26 (03) : 253 - 259
  • [29] Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus
    Wenbin Zhang
    Duanbin Li
    Yu Shan
    Yecheng Tao
    Qingqing Chen
    Tianli Hu
    Menghan Gao
    Zhezhe Chen
    Hangpan Jiang
    Changqin Du
    Min Wang
    Kai Guo
    Diabetology & Metabolic Syndrome, 15
  • [30] Derivation and Validation of a Risk Index to Predict All-Cause Mortality in Type 2 Diabetes Mellitus
    Wu, Christine Xia
    Tan, Woan Shin
    Toh, Matthias Paul Han Sim
    Heng, Bee Hoon
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 2 (02) : 88 - 95